| Phase 4 |
| NCT07604311 |
Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy |
IgA Nephropathy (IgAN) |
Recruiting |
2026-09-02 |
| NCT05728775 |
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac… |
Anesthesia |
Recruiting |
2025-08-26 |
| NCT06707194 |
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis |
Spondyloarthritis (SpA) |
Recruiting |
2025-06-26 |
| NCT06736860 |
Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of… |
Trauma Coagulopathy |
Recruiting |
2024-12-17 |
| NCT07839988 |
De-escalation Strategy of Tyrosine Kinase Inhibitors Before Treatment Discontinuation in… |
Chronic Myeloid Leukemia in Chronic Phase |
Not Yet Recruiting |
2026-09-24 |
| NCT07091994 |
A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy |
Ischemic Stroke, Acute |
Not Yet Recruiting |
2026-04-16 |
| NCT07528456 |
Butylphthalide for Brain Edema After Endovascular Treatment |
Acute Ischemic Stroke |
Not Yet Recruiting |
2026-04-14 |
| NCT07231276 |
Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric… |
HBV |
Not Yet Recruiting |
2025-11-17 |
| NCT06763666 |
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML |
Relapsed/Refractory AML |
Not Yet Recruiting |
2025-01-08 |
| Phase 3 |
| NCT07203352 |
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL |
Acute Lymphoblastic Leukemia |
Recruiting |
2025-10-02 |
| NCT06810791 |
HVA vs IA/DA or VA in the Treatment of ND HR-AML |
Newly Diagnosed Acute Myeloid Leukemia With High Risk |
Recruiting |
2025-02-06 |
| NCT03919552 |
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced… |
Cisplatin |
Recruiting |
2023-06-18 |
| Phase 2/3 |
| NCT07636486 |
Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological… |
Luspatercept |
Not Yet Recruiting |
2026-06-09 |
| NCT07603349 |
Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or… |
Gastric Adenocarcinoma |
Not Yet Recruiting |
2026-05-22 |
| NCT07539779 |
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With… |
Luspatercept |
Not Yet Recruiting |
2026-04-20 |
| NCT07264010 |
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a… |
Acute Myeloid Leukaemia (AML) |
Not Yet Recruiting |
2025-12-04 |
| NCT07174375 |
PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy |
Acute Ischemic Stroke |
Not Yet Recruiting |
2025-09-15 |
| NCT07052422 |
VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies… |
Older Patients |
Not Yet Recruiting |
2025-07-04 |
| Phase 2 |
| NCT07637448 |
EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC |
Lung Cancer Non-Small Cell Cancer (NSCLC) |
Recruiting |
2026-06-09 |
| NCT07539792 |
Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in… |
Sellar Tumor |
Recruiting |
2026-04-20 |
| NCT06885814 |
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
2026-04-14 |
| NCT07327788 |
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With… |
Hepatecellular Carcinoma |
Recruiting |
2026-01-13 |
| NCT06157996 |
Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With… |
Gastric Cancer |
Recruiting |
2025-05-30 |
| NCT06429696 |
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for… |
Small Cell Lung Cancer Extensive Stage |
Recruiting |
2025-05-28 |
| NCT06843889 |
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in… |
Locally Advanced Esophageal Squamous Cell Carcinoma |
Recruiting |
2025-04-16 |